Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic leukemia

Leukemia

Volumn 8, Issue SUPPL. 2, 1994, Pages

  Di Noto, R ^a   Schiavone, E M ^b   Ferrara, F ^c   Manzo, C ^a   Lo Pardo, C ^b   Del Vecchio, L ^b,d  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Laboratorio di Immuno citologia ^*  (Italy)

^c CARDARELLI HOSPITAL   (Italy)

^d NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD15 ANTIGEN; CD45 ANTIGEN; CELL ADHESION MOLECULE; INTEGRIN; RETINOIC ACID; SELECTIN;

ACUTE MYELOBLASTIC LEUKEMIA; AGRANULOCYTOSIS; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROMYELOCYTE;

EID: 0028598792     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-434.
2. Pardi R, Inverardi L, Bender JR. Regulatory mechanisms in leukocyte adhesion: flexible receptors for sophisticated travelers. Immunol Today 1992;13:224-230.
3. Maio M, Del Vecchio L. Expression and functional role of CD54/intercellular adhesion molecule-1 (ICAM-1) on human blood cells. Leuk Lymphoma 1992;8:23-33.
4. Liesveld JL, Winslow JM, Frediani KE, Ryan DH, Abboud CN. Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells. Blood 1993; 81:112-121.
5. Shimizu Y, Shaw S. Mucins in the mainstream. Nature 1993; 366:630-631.
6. Kansas GS, Muirhead MJ, Dailey MO. Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans. Blood 1990;76:2483-2492.
7. Bevilacqua MP, Nelson RM. Selectins. J Clin Invest 1993; 91:379-387.
8. Easton EW, Schiphorst WECM, Van Drunen E, Van Der Schoot E, Van Den Eijnden DH. Human myeloid alpha 3-fucosyltransferase is involved in the expression of the Sialyl-Lewis x determinant, a ligand for E- and P-selectin. Blood 1993;81:2978-2986.
9. Kuijpers TW. Terminal glycosyltransferase activity: a selective role in cell adhesion. Blood 1993;81:873-882.
10. Skacel PO, Edwards AJ, Harrison CT, Watkins WM. Enzymic control of the expression of the x determinant (CD15) in human myeloid cells during maturation: the regulatory role of 6′-sialyltransferase. Blood 1991;78:1452-1460.
11. Pinto A, Gattei V, Soligo D, Parravicini C, Del Vecchio L. New molecules burst at the leukocyte surface. Leukemia 1994; 8:347-358.
12. Stamenkovic I, Sgroi D, Aruffo A, Sy MS, Anderson T. The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45R0 on T cells and alpha2-6 sialyltransferase, CD75, on B cells. Cell 1991;66:1133-1144.
13. Thomas ML. The regulation of B- T-lymphocyte activation by the transmembrane protein tyrosine phosphatase CD45. Curr Opin Cell Biol 1994;6:247-252.
14. Warrell RP, Frankel SR, Miller VH, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS, Dmitrovsky E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). New Engl J Med 1991;324:1385-1393.
15. Chomienne C, Ballerini P, Balitrand N, Daniel MT, Fenaux P, Castaigne S, Degos L. All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. Blood 1990;76:1710-1717.
16. Warrell RP, de Thé H, Wang ZY, Degos L. Acute promyelocytic leukemia. New Engl J Med 1993;329:177-189.
17. Degos L. Annual guest lecture, Leukemia Research Fund (UK): differentiation therapy and leukemia. Leukemia 1993;7:766-772.
18. Ferrara F, Del Vecchio L, Antinolfi I, Prossomariti L, Mele G, Cimino R. Promyelocytic leukemoid reaction: a curable disease. 'Acute promyelocytic leukemia: a curable disease?' Rome , 11-12 November, 1993, 160(abstr.).
19. Del Vecchio L, Schiavone EM, Ferrara F, Pace E, Lo Pardo C, Pacetti M, Russo M, Cirillo D, Vacca C. Immunodiagnosis of acute leukemia displaying ectopic antigens: proposal for a classification of promiscuous phenotypes. Am J Hematol 1989; 31:173-180.
20. Ferrero D, Carlesso N, Pregno P, Gallo E, Pileri A. Self-renewal inhibition of acute myeloid leukemia clonogenic cells by biological inducers of differentiation. Leukemia 1992;6:100-106.
21. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicolerti I, Pelicci PG. The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 1993;74:423-431.
22. Hickstein DD, Grunvald E, Shumaker G, Baker DM, Back AL, Embree LJ, Yee E, Gollahon KA. Transfected leukocyte integrin CD11b/CD18 (Mac-1) mediates phorbol ester-activated, homotypic cell:cell adherence in the K562 cell line. Blood 1993; 82:2537-2545.
23. Ganser A, Seipelt G, Verbeek W, Ottmann OG, Maurer A, Kolbe K, Hess U, Elsner S, Reutzel R, Wormann B, Hiddemann W, Hoelzer D. Effect of combination therapy with all-trans retinoic acid and recombinant human granulocyte colony-stimulating factor in patients with myelodisplastic syndromes. Leukemia 1994;8:369-375.
24. Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J, Wiernik PH. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study. Leukemia 1994; 8:1108-1112.
25. Thomas ML. The leukocyte common antigen family. Ann Rev Immunol 1989;7:339-369.
26. Caldwell CW, Patterson WP, Toalson BD, Yesus YW. Surface and cytoplasmic expression of CD45 antigen isoforms in normal and malignant myeloid cell differentiation. Am J Clin Pathol 1991; 95:180-187.
27. Carlesso N, Ferrero D, Pregno P, Gallo E, Pileri A, Dianzani U. Expression of CD45 isoforms during differentiation and proliferation in 12 cases of acute myeloid leukemia. Tissue Antigens 1993;42:449.
28. Terstappen LWMM, Safford M, Loken MR. Flow cytometric analysis of human bone marrow III. Neutrophil maturation. Leukemia 1990;4:657-663.